Jul 21, 2026 08:00AM
Jul 8, 2026 05:07PM
Jul 8, 2026 05:07PM
Jul 1, 2026 12:00PM
Jun 15, 2026 04:01PM
Jun 15, 2026 04:01PM
Jun 15, 2026 09:31AM Stifel Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM) Post Release of Setmelanotide Data
Jun 13, 2026 08:01AM
Jun 13, 2026 08:01AM
Jun 12, 2026 04:01PM
Jun 12, 2026 04:01PM
Jun 3, 2026 04:43AM
May 29, 2026 08:00AM
May 28, 2026 08:00AM Rhythm Pharmaceuticals Announces Publication of New Bardet-Biedl Syndrome Diagnostic Algorithm in the American Journal of Medical Genetics
May 26, 2026 08:00AM
May 12, 2026 08:00AM
May 6, 2026 08:00AM
May 5, 2026 07:00AM
May 4, 2026 08:00AM
May 1, 2026 06:55AM
May 1, 2026 06:55AM Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothal
Apr 19, 2026 10:00AM
Apr 9, 2026 08:00AM
Apr 3, 2026 09:00AM
Apr 3, 2026 09:00AM
Mar 26, 2026 02:50PM
Mar 26, 2026 09:02AM
Mar 26, 2026 09:01AM Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalam
Mar 23, 2026 06:45AM
Mar 19, 2026 06:30PM
Mar 19, 2026 06:30PM
Mar 17, 2026 08:13AM
Mar 16, 2026 04:01PM
Mar 16, 2026 04:01PM
Mar 2, 2026 06:43AM Rhythm Pharmaceuticals (RYTM) PT Lowered to $140 at Canaccord
Mar 1, 2026 12:30PM
Mar 1, 2026 12:30PM
Feb 27, 2026 06:54AM
Feb 26, 2026 07:00AM
Feb 17, 2026 08:00AM
Feb 5, 2026 08:00AM
Jan 9, 2026 08:02AM Rhythm Pharmaceuticals reports $57M Q4 revenue, 50% annual growth
Jan 9, 2026 08:00AM
Dec 12, 2025 04:55AM
Dec 11, 2025 07:30AM
Dec 11, 2025 07:30AM
Dec 10, 2025 04:01PM
Dec 10, 2025 04:01PM
Nov 10, 2025 07:00AM Rhythm Pharmaceuticals Announces Presentation of Four Datasets at ObesityWeek® 2025
Nov 7, 2025 07:30AM

326,547 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All